InSysBio to announce the release of its new database Cytocon DB 1.1

MOSCOW, RUSSIA - Apr 1, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, has released its new Cytocon DB 1

PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials

NOTTINGHAM, UK - Apr 1, 2020 -

PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical TrialsNottingham, UK - 01 April 2020: PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trialsx

Optibrium and Intellegens achieve further success in Open Source Malaria initiative with in vitro validation of in silico generated compound

CAMBRIDGE, UNITED KINGDOM - Apr 1, 2020 - Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a unique Artificial Intelligence (AI) toolset, today announced they have reached a further significant milestone in their contribution to the Open Source Malaria (OSM) initiative

Check4Cancer launches new London ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics

LONDON, UK - Apr 1, 2020 - Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, launches a private ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics

Lifebit Provides Free Cloud Operating System, Data Hosting & Analysis Tools to COVID-19 Researchers

LONDON, UNITED KINGDOM - Mar 30, 2020 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced it is providing its premium Lifebit CloudOS license free to all researchers and teams working on COVID-19 efforts, including diagnostics, treatments, and vaccines

New analysis confirms value of investing public money to commercialise public science

LONDON, UNITED KINGDOM - Mar 30, 2020 - The UK Innovation and Science Seed Fund (UKI2S) has published an independent economic analysis showing how its investment and continuing support have generated benefits for early stage companies and for the UK economy as a whole

Real-time NAT enables remote COVID-19 testing

SYDNEY, AUSTRALIA - Mar 30, 2020 - Real-time NAT enables remote COVID-19 testingSydney, Australia, 30 March 2020: An Australian biotech has helped develop a mobile COVID-19 testing system that delivers highly accurate results within an hour, potentially slowing the spread of the virus

Microway Announces Delivery of Its Largest 2nd Gen AMD EPYC™ Processor-powered Cluster to Date

PLYMOUTH, MA, UNITED STATES - Mar 27, 2020 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has delivered a full-scale 2nd Gen AMD EPYC processor-powered cluster to a major insurance company

DermTech Announces Response to COVID-19

NEW YORK, NY, UNITED STATES - Mar 25, 2020 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today released the following letter from its CEO John Dobak, M

To Aid with COVID-19 Efforts, PhenoTips Offers Free Cloud-Hosted Genomics Software

TORONTO, ON, CANADA - Mar 24, 2020 - PhenoTips, a leading provider of precision medicine software, has announced their efforts to support genomic research during the COVID-19 pandemic in a blog post released on their website

WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic

PRINCETON, NJ - Mar 23, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, this week launched "The WCG Insights Program: Supporting best practices in a global pandemicx

Rho Experts Share Best Practices for Managing Risks in Clinical Trials

DURHAM - Mar 23, 2020 - Rho Experts Share Best Practices for Managing Risks in Clinical TrialsFree webinar offers insight into recent Good Clinical Practice (GCP) revisions on sponsor responsibilities for risk management WHAT:                 Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will outline and provide tips on the U

Global Flow Cytometry Market to Register Impressive Growth, Demand Upheld by Cancer and Stem Cell Research, Says Fact.MR

DUBLIN 2, IRELAND - Mar 23, 2020 - Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction

Creative Diagnostics Now Launches New Plant Pathogens Antibodies for Research Use

SHIRLEY, NY, UNITED STATES - Mar 23, 2020 - As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches high-quality plant pathogens antibodies that are suitable for use in ELISA or related immunoassays and can be ordered in bulk quantity

Creative Proteomics Released Choline and Choline Metabolites Analysis Service for Research Use

SHIRLEY, NY - Mar 20, 2020 - March 20, 2020, Creative Proteomics has released choline and choline metabolites analysis service to assist researchers in their biotechnological projects

KONZA to Deliver Actionable Patient Information to Participating Provider Organizations with Diameter Health Technology

FARMINGTON, CT, UNITED STATES - Mar 19, 2020 -   Diameter Health, developer of the leading platform for clinical data normalization and enhancement, today announced that KONZA, Inc

Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs

NOTTINGHAM, ENGLAND - Mar 19, 2020 - Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced today that the Center for Biologics Evaluation and Research (CBER), one of six main centers for the U

Robust, Powerful Compound Screening Platform Enhanced for Drug Screening Research

SHIRLEY, NY, UNITED STATES - Mar 19, 2020 - The New York-based chemical supplier BOC Sciences, also one of the active players in early drug discovery, recently announces to enhance its one-stop compound screening platform, which is efficient, economical and systematic, aiming to help scientists fulfill their screening needs arising from drug R&D projects

ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic

SAN FRANCISCO BAY AREA, CA, US - Mar 18, 2020 - Manassas, VA - March 18, 2020 - ATCC, the world's premier biological materials management and standards organization, today announced it is expanding its support for the U

CluePoints´ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations

KING OF PRUSSIA, PA, US - Mar 18, 2020 - CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak